Shares of Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) fell 1% on Monday . The company traded as low as €41.60 ($46.22) and last traded at €41.60 ($46.22). 161 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 1,927 shares. The stock had previously closed at €42.00 ($46.67).
Biotest Aktiengesellschaft Stock Performance
The company has a 50 day moving average price of €41.82 and a 200-day moving average price of €41.76. The company has a market cap of $823.26 million, a P/E ratio of 10.02 and a beta of 0.24. The company has a current ratio of 2.45, a quick ratio of 1.66 and a debt-to-equity ratio of 116.50.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Further Reading
- Five stocks we like better than Biotest Aktiengesellschaft
- How to Use the MarketBeat Dividend Calculator
- The Average 401k Balance by Age Explained
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Stock Sentiment Analysis: How it Works
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
